Registrar Performances in MIDP

University Hospital Center (CHU)

Status: Completed

Conditions: Minimally Invasive Distal Pancreatectomy

Treatments: Procedure: Minimally invasive distal pancreatectomy

Study type: Observational

Funder types: Other

Identifiers

NCT04429074

RECHMPL20_0348

Details and patient eligibility

About

This study aimed to determine whether registrar involvement in minimally invasive distal pancreatectomy (MIDP) was associated with adverse outcomes.

Full description

From January 2009 to March 2020, data of all consecutive patients requiring distal pancreatectomy in our public tertiary hospital were prospectively collected and retrospectively analyzed.

Registrars were progressively involved for MIDP since 2009 and their experience was: < 5 open pancreatic resections, < 5 MIDP and at least 30 advanced minimally invasive gastrointestinal resections.

Outcome of patients who underwent either distal pancreatectomy by the consultant or registrars were compared.

Our primary outcome was the conversion rate. The secondary outcomes were 90-days postoperative outcomes including CR-POPF defined and classified according to the 2016 ISGPF definition.

Enrollment: 71 patients

Sex: All

Ages: 18 to 99 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients who underwent minimally invasive distale pancreatectomy for benign or borderline pathology between 2009-2020

Exclusion criteria

• open distal pancreatectomy
• minimally invasive distal pancreatectomy for pancreatic cancer
• 20 first consecutive patients operated on by the consultant (learning curve)

Trial design

71 participants in 2 patient groups

Group 1 (Registrar)

Description:

Group 1 (Registrar): Patients who underwent minimally invasive distale pancreatectomy for benign or borderline pathology operated on by a registrar (young specialist surgeon)

Treatment:

Procedure: Minimally invasive distal pancreatectomy

Group 2 (Consultant)

Description:

Group 2 (Consultant): Patients who underwent minimally invasive distale pancreatectomy for benign or borderline pathology operated on by a consultant (expert)

Treatment:

Procedure: Minimally invasive distal pancreatectomy